The theRapeutic Effects of MEDical rehabilitation robotics for upper extremitY in patients with post-stroke hemiplegia (REMEDY): A randomized controlled study - REMEDY Study

Matsumoto Shuji0 sites60 target enrollmentJanuary 9, 2020

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Not specified
Sponsor: Matsumoto Shuji
Enrollment: 60
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The results of this study showed significant pre- and post-intervention improvements in most endpoints in the robot group. However, significant group differences (robot group vs. control group) could not be obtained for most endpoints. We would like to reconsider the number of cases, intervention methods (time per session, frequency, intervention period, etc.), and target settings for future research.

Registry

who.int

Start Date

January 9, 2020

End Date

August 11, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Matsumoto Shuji

Eligibility Criteria

Inclusion Criteria

•1\) Patients who can give written consent by themselves. If the subject has sufficient consent ability but writing is difficult due to a disability etc., it is confirmed that the subject agrees to participate in the research, and consent will be obtained by writing.
•2\) Patients at the age of 20 to 85 at the time of obtaining consent.
•3\) Patients in stroke recovery phase (within 6 months \[180 days] from onset of stroke).
•4\) Patients who have a first\-onset stroke and the type of stroke is cerebral infarction or cerebral hemorrhage (not targeted for subarachnoid hemorrhage).
•5\) Patients hospitalized for post\-stroke rehabilitation treatment.
•6\) Patients with upper limb BRS stages III to V in Brunnstrom Recovery Stage (BRS).
•7\) Patients whose general condition such as blood pressure, pulse and blood sugar level is stable.

Exclusion Criteria

•1\) Patients whose upper limb function training is judged to be difficult due to exertional dyspnea, heart failure, arrhythmia, myocardial infarction, etc.
•2\) Patients with a history of neurological disorders or upper extremity joint disorders that affect upper extremity function.
•3\) Patients who have severe advanced disease such as degenerative shoulder and elbow arthropathy, uncontrolled rheumatoid arthritis, scoliosis, and osteoporosis, and it is judged that the upper extremity function training is difficult or their symptoms are exacerbated by upper limb training.
•4\) Patients with severe liver disorder, kidney disorder, cardiovascular disease (with serious illness, Ministry of Health, Labor and Welfare, Pharmaceutical Affairs Bureau, Safety Division Manager, Notification No. 80, Severity classification criteria for side effects such as drugs ) Judgment based on grade 3 in).
•5\) Patients with severe brain dysfunction and higher brain dysfunction such as ataxia and aphasia.
•6\) contraindications of electrical and vibrational stimulation.
•Embedded electronic devices (such as pacemakers) users, patients with heart disease, malignancy, tuberculosis, or acute diseases, in extreme weakness, in pregnant women or those who may have pregnancy, perception by atopy etc. Those who may have hypersensitivity, blood flow problems, those who use metal implants, or those who have a history of or suspected epilepsy.
•Others, who the doctor deems inappropriate.
•In the following cases, it is at the discretion of the doctor.
•Blood pressure abnormality, heated person or infection